Dyadic International (NASDAQ:DYAI) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Dyadic International (NASDAQ:DYAI) issued its earnings results on Tuesday. The biotechnology company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.06, Zacks reports. Dyadic International had a negative return on equity of 140.01% and a negative net margin of 188.09%. The business had revenue of $1.96 million for the quarter, compared to analysts’ expectations of $1.05 million. During the same period in the previous year, the firm posted ($0.06) EPS.

Dyadic International Stock Performance

Shares of Dyadic International stock traded down $0.02 on Wednesday, reaching $1.12. The company had a trading volume of 22,804 shares, compared to its average volume of 47,767. The company has a debt-to-equity ratio of 1.72, a current ratio of 5.39 and a quick ratio of 5.39. The firm’s 50 day moving average price is $1.13 and its two-hundred day moving average price is $1.42. Dyadic International has a 52-week low of $0.93 and a 52-week high of $2.67.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.